Perpetuity Health To Wealth (H2w) Rising Fund

AIF

Perpetuity Ventures LLP healthcare-biased listed-equity Cat III AIF (H2W Rising Fund)

What changed since Mar 2026

vs Jun 2026

Bought / raised

No stakes raised.

Sold / trimmed

Windlas Biotech Limited WINDLAS

−0.07 pp 1.18% → 1.11%

Disclosed holdings (1)

Latest filings · Jun 2026

Windlas Biotech Limited WINDLAS

1.11%

From company shareholding-pattern filings. Holders are named only above SEBI's 1% threshold, so "off the list" may mean a full exit or a trim to just under 1% — the filing cannot distinguish the two. Mutual-fund entries are per scheme, not per fund house.